Comprehensive Study Guide for Neuroanesthesia and Cerebral Physiology
Anesthetic Agents and Cerebral Physiology
The majority of anesthetic agents alter intracranial pressure () primarily by decreasing cerebrovascular resistance (). This process occurs through cerebrovascular dilation and a dose-dependent impairment of cerebral autoregulation. The physiological results of these changes include increases in and cerebral blood volume () alongside a decrease in the cerebral metabolic rate of oxygen (). Inhalation agents specifically decrease mean arterial pressure () while increasing , which combined reduces the cerebral perfusion pressure (). The relative effect of these agents on the cerebral vasculature follows the hierarchy of .
Inhalation Agents and Neuroprotection
Isoflurane exhibits specific neuroprotective properties. Cerebral blood flow () remains relatively unaltered at concentrations between and . However, when the concentration is increased to , the doubles. Isoflurane is noted for potentially enhancing the reactivity of vessels, though cerebral autoregulation becomes impaired at doses greater than . is depressed by isoflurane, with progressive metabolic depression occurring above ; the electroencephalogram () becomes isoelectric at . This suggests that clinically relevant doses may protect against ischemic events.
Proposed mechanisms for this neuroprotection include the activation of -dependent channels, the upregulation of nitric oxide synthase, and the reduction of excitotoxic stressors and . Additionally, isoflurane may augment peri-ischemic and upregulate antiapoptotic factors, such as mitogen-activated protein kinases. Desflurane and Sevoflurane offer different clinical profiles. Desflurane has low blood/gas solubility, allowing for rapid emergence and immediate postoperative neurologic evaluation, though it may increase more than others, potentially resulting in higher . Sevoflurane is considered less vasoactive, produces the least cerebral vasodilation, and preserves cerebral autoregulation up to .
All inhalation agents increase , , and , though mild hyperventilation can attenuate these dose-dependent increases. They all preserve cerebrovascular reactivity and function as concentration-dependent vasodilators. In intracranial surgery, sevoflurane is often the preferred choice for maintenance anesthesia.
Nitrous Oxide and Neurosurgery Considerations
Nitrous oxide () increases , , and . Its effect on cerebral hemodynamics is variable; hyperventilation or the administration of intravenous anesthetics can reduce the increase in and . When is combined with less than of a volatile agent, increases in and occur. At , can increase by or more, typically increasing flow in anterior regions while decreasing it in posterior regions.
Controversy exists regarding due to potential neurotoxicity; when used for more than , metabolic breakdown products accumulate. It is associated with megaloblastic anemia, leukopenia, impaired fetal development, and immunosuppression. Critically, because is more soluble than nitrogen, it expands closed gas spaces. It must be avoided in the presence of intracranial or intravascular air, such as pneumocephalus. If used, it should be discontinued before the closure of the dura to mitigate iatrogenic pneumocephalus formation.
Clinical suggestions for omitting include cases involving recent craniotomy or craniofacial trauma, instances where evoked potential monitoring signal quality is inadequate, patients with clinical evidence of moderate to severe increases, a clinically appreciated "tight-brain," or cases expected to last longer than .
Intravenous Agents and neurosurgical Considerations
Propofol is a popular agent for neurosurgery, providing dose-dependent reductions in and by . While may decrease due to systemic hypotension following bolus dosing, the reduction in appears independent of systemic changes, likely due to metabolic depression and cerebral vasoconstriction. Etomidate also reduces and while maintaining through cerebral vasoconstriction. However, its disadvantages include myoclonia, thrombophlebitis, nausea/vomiting, and adrenocortical suppression. This suppression is a concern in critically ill patients with sepsis or traumatic brain injury (). If etomidate is used, empirical adrenal replacement therapy for should be considered.
Dexmedetomidine is an receptor agonist that produces sedation without respiratory depression. It is advantageous for "wake-up" tests and brain mapping during awake craniotomies because it does not interfere with electrophysiologic monitoring, although it may cause dose-dependent decreases in motor evoked potential () amplitude and Bispectral Index () values. It decreases via vasoconstriction but does not significantly alter or . Its central sympatholytic effects assist with antishivering and reducing the neuroendocrine response to surgery.
Opioids, Benzodiazepines, and Ketamine
Synthetic opioids cause dose-related decreases in and (), reducing to approximately . While they generally offer steady hemodynamics, increases in can occur via autoregulation if decreases. Sufentanil has the highest therapeutic index, while alfentanil produces the greatest decreases in and . Remifentanil has an ultrashort duration of action but carries a risk of postoperative hyperalgesia. Meperidine must be avoided due to its metabolite, normeperidine, which causes seizures. Benzodiazepines provide anxiolytic and anticonvulsant effects with dose-dependent decreases in and . Flumazenil reversal must be handled carefully to avoid rebound increases in and or seizures.
Ketamine acts via a dissociative mechanism and was traditionally avoid in neurosurgery because it increases by and increases resistance to reabsorption, both elevating . However, recent studies suggest it may not raise as significantly as once thought. It provides stable hemodynamics and neuroprotection through noncompetitive antagonism. On the , ketamine causes a transition from alpha to theta waves upon loss of consciousness and does not decrease values.
Neuromuscular Blocking Agents (NMBA)
Nondepolarizing NMBAs do not affect or . However, patients with upper motor neuron diseases may show resistance on the hemiparetic side; Train-of-Four () monitoring should occur on the unaffected side. Chronic anticonvulsant therapy () induces , leading to increased dosage requirements and decreased duration of action for these agents. Depolarizing NMBAs (succinylcholine) cause muscle fasciculations that can transiently increase by for . Succinylcholine is contraindicated in patients with neurologic or denervated muscles due to the risk of hyperkalemia and should be avoided in cases of , coma, encephalitis, or severe burns. If a rapid sequence induction () is required, Rocuronium at is an alternative.
Antihypertensive Management
Beta-blockers like Esmolol () are used to control sympathetic stimulation during intubation with negligible effects on . Labetalol is preferred for controlling emergence hypertension but is more likely to cause bradycardia. Vasodilators such as sodium nitroprusside () and nitroglycerin () are potent dilators of capacitance vessels and can increase and . In patients with "abnormal elastance," these can lead to intracranial hypertension and potentially herniation. The effect of may be attenuated by hyperventilation and propofol.
Intracranial Pressure (ICP) Determinants and Monitoring
represents supratentorial cerebrospinal fluid () pressure, measured in the lateral ventricle or subarachnoid space. The Monro-Kellie Doctrine states that the cranium is a rigid container; an increase in one component—brain (), blood, intracellular water, or —must be compensated for by a reduction in another, or will rise. Intracranial contents total approximately . Normal is , while intracranial hypertension is defined as . is calculated as .
The gold standard for measurement is the intraventricular catheter, which allows for both precision monitoring and continuous drainage of . The most frequent complication is infection (), especially if the duration exceeds . Intraparenchymal probes are easier to transport and have a lower infection risk (). These are recommended for severe (GCS ) or patients with abnormal scans and specific clinical markers (age , , or motor posturing).
ICP Waveforms and Intracranial Hypertension
The waveform is pulsatile with three components: (arterial/systolic), (tidal), and (dicrotic). In healthy states, is the tallest; as increases, and surpass . Lundberg A waves (plateau waves) reflect sustained elevations of lasting , indicating critically low compliance. These are often triggered by systemic hypotension leads to cerebral vasodilation, which further increases and , creating a dangerous cycle. Symptoms of intracranial hypertension include headache, nausea, papilledema, focal deficits, and decreased consciousness. If , decreases, leading to ischemia and edema.
Techniques for ICP Reduction
Hyperventilation lowers , causing vasoconstriction via the metabolic mechanism of autoregulation. decreases by approximately for every g decrease in . This effect only lasts as pH equilibrates. Excessive hypocapnia can cause ischemia; therefore, it is not recommended in the first after . The target is typically . External ventricular drains () or ventriculoperitoneal () shunts can divert to manage hydrocephalus. Surgical decompression (internal or external) is considered a last resort for uncontrollable .
Hypothermia decreases by for every decrease in core temperature. The goal is often a bladder temperature of for after trauma. Pharmacologic management includes loop diuretics and osmotic diuretics like Mannitol (). Rapid Mannitol administration can cause transient increases in and due to vasodilation. Hypertonic saline ( or ) creates an osmolar gradient that shrinks brain tissue and increases and . Serum sodium must be checked to remain below ; a rise faster than in can cause osmotic demyelination syndrome.
Corticosteroids (Dexamethasone every ) are indicated for edema related to brain tumors but are harmful in patients (per the CRASH trial). Barbiturates may be used for refractory hypertension to induce burst suppression on the , though this leads to hypotension and prevents neurological examinations.
Arteriovenous Difference of Oxygen (AVDO2)
When is constant, changes in reflect changes in ( is inversely related to ). It is measured via a catheter in the internal jugular (). The formula for calculation is:
Intraoperative Neurophysiologic Monitoring (IOM)
IOM identifies brain regions at risk and improves outcomes. Common modalities include , somatosensory-evoked potentials (), and brainstem auditory-evoked potentials (). The Dorsal Column-Medial Lemniscal () pathway transmits sensory signals: the primary neuron enters the dorsal root and travels to the medulla, the secondary neuron crosses to the opposite side and travels to the thalamus, and the tertiary neuron reaches the somatosensory cortex. The anterolateral pathway for pain immediately synapses and crosses in the spinal cord before ascending to the thalamus.
waves are classified by frequency: Alpha (, resting), Beta (, focused), Theta (, stress/disorder), and Delta (, deep sleep/disease). Deep anesthesia and ischemia both present with slower, larger waveforms. monitoring requires signal averaging because amplitudes are small (). Volatile agents and depress ; MAC should be kept below . Conversely, etomidate and ketamine increase amplitude by . Hypothermia increases latency by for every decrease in temperature.
assesses brainstem function and is resistant to most anesthetic drugs, though decreases amplitude and propofol increases latency. It is helpful when the auditory apparatus is at risk. is used for facial nerve monitoring (standard for acoustic tumors). Neuromuscular blockers should generally be avoided when monitoring . Motor Evoked Potentials () assess corticospinal tracts but are very sensitive to inhaled agents; Total IV Anesthesia () with propofol is the preferred anesthetic technique.
Cerebral Oximetry
Cerebral oximetry uses Near-Infrared Spectroscopy () and the Beer-Lambert Law to measure regional venous oxygen saturation (). It is a non-invasive monitor typically placed on the forehead. Because cerebral blood volume is roughly venous and arterial, primarily measures oxygen extraction on the venous side. A change of more than from baseline suggests reduced cerebral oxygenation. Factors influencing readings include , , hemoglobin levels, and scalp hypoxia, which can contaminate the signal.